Effect of Topical Aqueous Suppressant on Anatomic and Functional Response to Intravitreal Anti-vascular Endothelial Growth Factor Injections in Age-related Macular Degeneration, Retinal Vein Occlusions or Diabetic Macular Edema.
Phase of Trial: Phase II
Latest Information Update: 01 Mar 2017
At a glance
- Drugs Dorzolamide/timolol (Primary)
- Indications Diabetic macular oedema; Retinal vein occlusion; Wet age-related macular degeneration
- Focus Therapeutic Use
- 17 Feb 2017 Status changed to recruiting.
- 14 Oct 2015 New trial record